2 mg ETH267 (Doxazosin 2 mg)
Pill imprint 2 mg ETH267 has been identified as Doxazosin mesylate 2 mg.
Doxazosin is used in the treatment of high blood pressure; benign prostatic hyperplasia; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 2 mg ETH267 (Doxazosin 2 mg)
- 2 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- hydrated alumina
sodium lauryl sulfate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
|NDC Code||Manufacturer / Repackager|
|67253-0381||DAVA Pharmaceuticals, Inc.|
|54569-5169||A S Medication Solutions LLC (repackager)|
|58016-0997||Southwood Pharmaceuticals Inc (repackager)|
|33358-0116||Core Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.